Inventiva selected to present the results of its NATIVE Phase IIb clinical trial with lanifibranor in NASH during a plenary session at The Liver Meeting Digital Experience™ 2020

    NEXT STORY
    Iovance Biotherapeutics Provides Update for Lifileucel in Metastatic Melanoma
    PREV STORY
    Global Aquaculture Vaccines Market Is Expected to Reach USD 336.12 Million by 2027 : Fior Markets
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy

    First Patient Enrolled in DISRUPT CAD III, the U.S. FDA IDE Study for IVL ...

    author_avatar
    NASDAQ Market News

    Global Capsule Endoscope Systems Industry

    author_avatar
    NASDAQ Market News

    Tabula Rasa HealthCare Expands Medication Risk Mitigation Offerings to Western Europe

    MOORESTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), ...

    author_avatar
    NASDAQ Market News